Temasek Holdings
BIIB icon

Temasek Holdings’s Biogen BIIB Stock Holding History

Temasek Holdings’s Portfolio BIIB Stock Details BIIB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q3 		– Sell
-118,644
Closed -$34.4M – 57
2018
Q2 		$34.4M Hold
118,644
– – 0.18% 46
2018
Q1 		$32.5M Hold
118,644
– – 0.18% 44
2017
Q4 		$37.8M Hold
118,644
– – 0.23% 40
2017
Q3 		$37.1M Buy
118,644
+23,418
+25% +$6.93M 0.22% 39
2017
Q2 		$25.8M Buy
+95,226
New +$25.2M 0.17% 37

Other funds holding BIIB

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return

Temasek Holdings's BIIB Position: Q3 2018 in Review

Temasek Holdings sold out of Biogen (BIIB) in Q3 2018, closing a stake of 118,644 shares — an estimated $34.4M sold.

Temasek Holdings first reported a position in BIIB in Q2 2017 and held it in 5 quarters. The position peaked at $37.8M in Q4 2017. 1,145 funds tracked by Wall St. Rank hold BIIB as of Q3 2018.

  • Temasek Holdings reported no remaining Biogen position as of Q3 2018 after selling out during the quarter.
  • Temasek Holdings sold 118,644 Biogen shares in Q3 2018, an estimated $34.4M.
  • Temasek Holdings first reported a position in Biogen in Q2 2017 and held it in 5 quarters.
  • Temasek Holdings's Biogen position peaked at $37.8M in Q4 2017.
  • 1,145 funds tracked by Wall St. Rank held Biogen as of Q3 2018.

Based on Temasek Holdings's 13F filing for Q3 2018, filed 14 Nov 2018.